D&A at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Medpace Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medpace Holdings, Inc.'s d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Medpace Holdings, Inc.'s D&A?
- Medpace Holdings, Inc. (MEDP) reported D&A of $6.75M in Q1 2026.
- How has Medpace Holdings, Inc.'s D&A changed year-over-year?
- Medpace Holdings, Inc.'s D&A increased by 0.9% year-over-year, from $6.69M to $6.75M.
- What is the long-term trend for Medpace Holdings, Inc.'s D&A?
- Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s D&A has grown at a 14.2% compound annual growth rate (CAGR), from $16.01M to $27.18M.
- What does D&A mean?
- Non-cash expenses that account for the wear and tear or expiration of company assets.
- How do you interpret D&A?
- Higher values indicate significant investment in capital assets, while lower values may suggest aging infrastructure or a shift toward asset-light operations.
- How does D&A compare across companies?
- Varies based on capital intensity; CROs are generally less capital-intensive than manufacturing firms.